A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)

PHASE2CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Plantar Fasciitis
Interventions
BIOLOGICAL

Collagenase Clostridium Histolyticum (CCH)

Biologic: Intrafascial injection

BIOLOGICAL

Placebo

Intrafascial injection

Trial Locations (39)

19355

Endo Site 36, Malvern

21122

Endo Clinical Site 2, Pasadena

23434

Endo Site 12, Suffolk

23606

Endo Site 32, Newport News

30038

Endo Site 23, Stonecrest

30043

Endo Site 7, Lawrenceville

33073

Endo Site 37, Coconut Creek

33172

Endo Site 14, Sweetwater

33782

Endo Clinical Site 3, Pinellas Park

49525

Endo Site 19, Grand Rapids

59804

Endo Site 27, Missoula

60064

Endo Site 31, North Chicago

62269

Endo Site 28, O'Fallon

66211

Endo Site 33, Overland Park

71101

Endo Site 35, Shreveport

73160

Endo Site 25, Moore

75208

Endo Site 17, Dallas

75235

Endo Site 26, Dallas

75251

Endo Site 18, Dallas

76021

Endo Clinical Site 4, Bedford

76028

Endo Site 24, Burleson

76104

Endo Site 30, Fort Worth

77027

Endo Site 15, Houston

78229

Endo Site 34, San Antonio

78258

Endo Site 22, San Antonio

78501

Endo Site 9, McAllen

78628

Endo Clinical Site 1, Georgetown

84107

Endo Clinical Site 5, Salt Lake City

85712

Endo Site 8, Tucson

90010

Endo Site 16, Los Angeles

90063

Endo Site 40, Los Angeles

91356

Endo Site 10, Tarzana

92024

Endo Site 6, Encinitas

92882

Endo Site 13, Corona

93710

Endo Site 11, Fresno

94115

Endo Site 21, San Francisco

94546

Endo Site 20, Castro Valley

97202

Endo Site 39, Portland

07675

Endo Site 38, Westwood

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY